Category: Press Release - Page 60 - Psychedelic Alpha

Read more about the article atai Life Sciences Company Kures Therapeutics Appoints Dr. Chad Beyer as Chief Executive Officer

atai Life Sciences Company Kures Therapeutics Appoints Dr. Chad Beyer as Chief Executive Officer

Post published:July 1, 2022
Post category:Press Release

Read more about the article Algernon Pharmaceuticals Announces Pricing of Public Offering of Units

Algernon Pharmaceuticals Announces Pricing of Public Offering of Units

Post published:June 29, 2022
Post category:Press Release

Read more about the article Tryp Therapeutics Strengthens IP Portfolio with Provisional Patent Application for Binge Eating Disorder Treatment

Tryp Therapeutics Strengthens IP Portfolio with Provisional Patent Application for Binge Eating Disorder Treatment

Post published:June 29, 2022
Post category:Press Release

Read more about the article Mindset Pharma Announces Development of Novel, Optimized, Intranasal Formulation

Mindset Pharma Announces Development of Novel, Optimized, Intranasal Formulation

Post published:June 29, 2022
Post category:Press Release

Read more about the article Optimi Health Initiates Agreement With SABI Mind For Therapeutic Supplies Of Psilocybin, MDMA

Optimi Health Initiates Agreement With SABI Mind For Therapeutic Supplies Of Psilocybin, MDMA

Post published:June 29, 2022
Post category:Press Release

Read more about the article HAVN Life Enters Supply Agreement with MPB Group Inc.

HAVN Life Enters Supply Agreement with MPB Group Inc.

Post published:June 29, 2022
Post category:Press Release

Read more about the article PsyBio Therapeutics to Seek Approval of Proposed Share Consolidation at Annual and Special Meeting of Shareholders

PsyBio Therapeutics to Seek Approval of Proposed Share Consolidation at Annual and Special Meeting of Shareholders

Post published:June 29, 2022
Post category:Press Release

Numinus Unveils New Logo and Brand Identity

Post published:June 28, 2022
Post category:Press Release

Read more about the article Bright Minds Biosciences Announces Changes to its Executive Leadership Team, Marking the Transition to a Development Organization

Bright Minds Biosciences Announces Changes to its Executive Leadership Team, Marking the Transition to a Development Organization

Post published:June 27, 2022
Post category:Press Release

Read more about the article Incannex to Present at the H.C. Wainwright First Annual Mental Health Conference

Incannex to Present at the H.C. Wainwright First Annual Mental Health Conference

Post published:June 27, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.